Skip to main content
Back
Watch Compare

Candel Therapeutics, Inc.

Data quality: 83%
CADL
Nasdaq Manufacturing Chemicals
$4.83
▲ $0.03 (0.63%)
Mkt Cap: 353.42 M
Price
$4.83
Mkt Cap
353.42 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -38.90 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-44.83%
Above sector avg (-53.34%)
ROIC-43.85%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio8.25
Interest Coverage-22.78

Valuation

PE (TTM)
-9.26
Below sector avg (-1.47)
P/B Ratio4.41
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -9.3 -1.5
P/B 4.4 1.6
ROE % -44.8 -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

8 analysts
Buy
Current
$4.83
+290.8%
Target
$18.88
$7.00
$19.50
$26.00
Forecast
Forward P/E -7.55
Forward EPS -$0.64
Est. Revenue 54.63 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.64
-$0.64 – -$0.64
 54.63 M 1
FY2026 -$0.77
-$0.77 – -$0.77
 0.0 1

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.24 -$0.29 -23.8%
Q32025 -$0.17 -$0.23 -37.1%
Q22025 -$0.18 -$0.20 -16.6%
Q12025 -$0.24 -$0.14 +42.9%

ETFs Holding This Stock

GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.01% weight
GCSIX GCSIX
0.01% weight
GCSSX GCSSX
0.01% weight
GCSAX GCSAX
0.01% weight
GCSCX GCSCX
0.01% weight
GDSRX GDSRX
0.01% weight
GDSTX GDSTX
0.01% weight
GMAPX GMAPX
0.01% weight
GCSUX GCSUX
0.01% weight
VVICX VVICX
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -38.18 M
ROE -44.83% ROA -38.27%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -38.90 M
ROIC -43.85% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 8.25
Interest Coverage -22.78 Asset Turnover N/A
Working Capital 79.21 M Tangible Book Value 80.12 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -9.26 Forward P/E N/A
P/B Ratio 4.41 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -11.01%
Market Cap 353.42 M Enterprise Value 266.45 M
Per Share
EPS (Diluted TTM) -0.72 Revenue / Share N/A
FCF / Share -0.53 OCF / Share -0.52
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 101.88%
SBC-Adj. FCF -42.61 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — 125,000.0 125,000.0 125,000.0
Net Income -38.18 M -55.18 M -37.94 M -18.79 M -36.12 M
EPS (Diluted) -0.72 -1.74 -1.31 -0.65 —
Gross Profit — — — — —
Operating Income -48.27 M -33.37 M -38.39 M -34.72 M -25.73 M
EBITDA — — — — —
R&D Expenses 30.50 M 19.31 M 24.51 M 20.79 M 15.18 M
SG&A Expenses — — — — —
D&A — — — 778,000.0 232,000.0
Interest Expense 2.12 M -2.09 M 2.60 M — —
Income Tax 0.0 0.0 0.0 0.0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 125.20 M 106.87 M 41.20 M 77.69 M 89.21 M
Total Liabilities 73.27 M 40.54 M 28.46 M 29.98 M 25.07 M
Shareholders' Equity 51.92 M 66.33 M 12.75 M 47.71 M 64.14 M
Total Debt — 1.73 M 11.63 M — 560,000.0
Cash & Equivalents 119.73 M 102.65 M 35.41 M 70.06 M 82.64 M
Current Assets 121.39 M 103.80 M 36.80 M 71.95 M 84.95 M
Current Liabilities 9.00 M 37.53 M 14.18 M 5.62 M 5.36 M